Publications

1.   Initiating or Switching to Insulin Degludec/Insulin Aspart in Adults with Type 2 Diabetes in Malaysia: Results from a Prospective, Non-interventional Real-World Study

2.   A Randomized, Placebo-Controlled Crossover Study to Evaluate Postprandial Glucometabolic Effects of Mulberry Leaf Extract, Vitamin D, Chromium, and Fiber in People with Type 2 Diabetes

3.   Initiating or Switching to Insulin Degludec/Insulin Aspart in Adults with Type 2 Diabetes: A Real-World, Prospective, Non-interventional Study Across Six Countries

4.   Current Insights on Dyslipidaemia Management for Prevention of Atherosclerotic Cardiovascular Disease: A Malaysian Perspective

5.   Variation in the prevalence, awareness, and control of diabetes in a multiethnic population: A nationwide population study in Malaysia

6.   Diabetes and Ramadan: Practical guidelines 2021

7.  Effect of a Web-Based Management Guide on Risk Factors in Patients with Type 2 Diabetes and Diabetic Kidney Disease: A JADE Randomized Clinical Trial  

1.   Initiating or Switching to Insulin Degludec/Insulin Aspart in Adults with Type 2 Diabetes in Malaysia: Results from a Prospective, Non-interventional Real-World Study  

2.   A Randomized, Placebo-Controlled Crossover Study to Evaluate Postprandial Glucometabolic Effects of Mulberry Leaf Extract, Vitamin D, Chromium, and Fiber in People with Type 2 Diabetes 

3.   Current Insights on Dyslipidaemia Management for Prevention of Atherosclerotic Cardiovascular Disease: A Malaysian Perspective   

4.   Safety of sodium-glucose cotransporter 2 inhibitors in Asian type 2 diabetes populations  

5.   Initiating or Switching to Insulin Degludec/Insulin Aspart in Adults with Type 2 Diabetes: A Real-World, Prospective, Non-interventional Study Across Six Countries

6.   Needlestick Injuries With Insulin Injections: Risk Factors, Concerns, and Implications of the Use of Safety Pen Needles in the Asia-Pacific Region  

7.   A Randomized, Placebo-Controlled Crossover Study to Evaluate the Effect of a Natural Powder Blend (Mulberry Leaf Extract [MLE], Vitamin D, Chromium, and Fiber) on Postprandial (PP) Metabolic Response in Type 2 Diabetes (T2D)  

8.  IDegAsp treatment in adults with type 2 diabetes in real-world practice: clinical outcomes by prior therapy subgroup  

9.   IDegAsp treatment in adults with type 2 diabetes in real-world practice: subgroup analysis by dosing frequency

10.  Effect of a Web-Based Management Guide on Risk Factors in Patients With Type 2 Diabetes and Diabetic Kidney Disease A JADE Randomized Clinical Trial

11.   Diabetes and Ramadan: Practical guidelines 2021

12.   ARISE-a prospective, non-interventional, single-arm study assessing clinical parameters associated with the use of insulin degludec/insulin aspart in patients with type 2 diabetes in realworld settings: rationale and design    

13. Comparison of Vitamin D Levels, Bone Metabolic Marker Levels, and Bone Mineral Density among Patients with Thyroid Disease: A Cross-Sectional Study   

14. Using a Diabetes Kidney Disease (DKD) Registry to Treat to Multiple Targets (TMT)-A JADE Technology-Based RCT   

15.Efficacy and Safety of Pioglitazone Monotherapy in Type 2 Diabetes Mellitus: A Systematic Review and Meta-Analysis of Randomised Controlled Trials    

16.Efficacy of Rosuvastatin in Children With Homozygous Familial Hypercholesterolemia and Association With Underlying Genetic Mutations   

17.A Consensus of Key Opinion Leaders on the Management of Pre-diabetes in the Asia-Pacific Region   

18.DiabCare Malaysia: Journey to improving diabetes care in Malaysia   

19.DNA Methylation: An Epigenetic Insight into Type 2 Diabetes Mellitus   

20.A RANDOMIZED, DOUBLE-BLIND, PLACEBO-CONTROLLED, MULTI-CENTER, CROSS-OVER STUDY OF ROSUVASTATIN IN CHILDREN AND ADOLESCENTS (AGED 6 TO 18 YEARS) WITH HOMOZYGOUS FAMILIAL HYPERCHOLESTEROLEMIA (HOFH)  

21.Safety and effectiveness of insulin detemir in type 2 diabetes: Results from the ASEAN cohort of the A1chieve study  

22.BONE MAXIMUM BREAKING FORCE, FAT FREE DRY WEIGHT, FOLLICLE STIMULATING HORMONE AND LUTEINIZING HORMONE IN RESPONSE TO DIFFERENT INTENSITIES OF JUMPING EXERCISES COMBINED WITH MALAYSIAN TUALANG HONEY IN FEMALE RATS   

23.The impact of a disease management program (COACH) on the attainment of better cardiovascular risk control in dyslipidaemic patients at primary care centres (The DISSEMINATE Study): a randomised controlled trial   

24.Assessing Glycaemic Control in Primary Care Setting: A Randomized Control Trial between Fasting and 2 Hours Postprandial Blood Glucose Monitoring in Type 2 Diabetic Patients Attending Klinik Rawatan Keluarga, Hospital Universiti Sains Malaysia, Kelantan   

25.Metabolic Syndrome among Patients Undergoing Coronary Angiogram in a Tertiary Center East Coast of Peninsular Malaysia   

26.Variation in the Prevalence, Awareness, and Control of Diabetes in a Multiethnic Population: A Nationwide Population Study in Malaysia  Variation in the Prevalence, Awareness, and Control of Diabetes in a Multiethnic Population: A Nationwide Population Study in Malaysia  

27.MJMS AND THE CHALLENGES OF A RESEARCH UNIVERSITY   

28.An audit on diabetes management in Asian patients treated by specialists: the Diabcare-Asia 1998 and 2003 studie 

29.ENSURING THE STANDARD OF MEDICAL GRADUATES IN MALAYSIA   

30.Comparisons of the outcomes on control, type of management and complications status in early onset and late onset type 2 diabetes in Asia   

31.OPEN LABEL CLINICAL TRIAL TO STUDY ADVERSE EFFECTS AND TOLERANCE TO DRY POWDER OF THE AERIAL PART OF ANDROGRAPHIS PANICULATA IN PATIENTS TYPE 2 WITH DIABETES MELLITUS

32.A PRELIMENARY RESULT OF THE CARDIOVASCULAR RISK FACTORS INTERVENTION STUDY (PIKOM STUDY): DIABETES MELLITUS, HYPERTENSION AND THEIR ASSOCIATED FACTORS

1.      Efficacy and safety of pioglitazone monotherapy in type 2 diabetes mellitus: a systematic review and meta-analysis of randomised controlled trials

2.   Comparisons of the outcomes on control, type of management and complications status in early onset and late onset type 2 diabetes in Asia 

3.    Variation in the prevalence, awareness, and control of diabetes in a multiethnic population: a nationwide population study in Malaysia

4.    Diabetes and Ramadan: practical guidelines 2021 

5.    An audit on diabetes management in Asian patients treated by specialists: the Diabcare-Asia 1998 and 2003 studies 

6.   Efficacy of rosuvastatin in children with homozygous familial hypercholesterolemia and association with underlying genetic mutations  

7.    Open label clinical trial to study adverse effects and tolerance to dry powder of the aerial part of Andrographis paniculata in patients type 2 with diabetes mellitus 

8.   DNA methylation: an epigenetic insight into type 2 diabetes mellitus 

9.   Current clinical status and complications among type 2 diabetic patients in Universiti Sains Malaysia hospital 

10. The impact of a disease management program (COACH) on the attainment of better cardiovascular risk control in dyslipidaemic patients at primary care centres (The DISSEMINATE Study): a randomised controlled trial

11. Dyslipidaemic pattern of patients with type 2 diabetes mellitus 

12. Effect of a web-based management guide on risk factors in patients with type 2 diabetes and diabetic kidney disease: a JADE randomized clinical trial  

13. A consensus of key opinion leaders on the management of pre-diabetes in the Asia-Pacific region 

14. A Summary of the Consensus for the Management of Thyroid Disorders in Malaysia 

15. A prelimenary result of the cardiovascular risk factors intervention study (Pikom study): Diabetes mellitus, hypertension and their associated factors 

16. DiabCare 2013: A cross-sectional study of hospital based diabetes care delivery and prevention of diabetes related complications in Malaysia  

17. Safety and effectiveness of insulin detemir in type 2 diabetes: results from the ASEAN cohort of the A1chieve study  

18. Initiating or switching to insulin degludec/insulin aspart in adults with type 2 diabetes: a real-world, prospective, non-interventional study across six countries  

19. ARISE—a prospective, non-interventional, single-arm study assessing clinical parameters associated with the use of insulin degludec/insulin aspart in patients with type 2 diabetes in real-world settings: rationale and design

20. Comparison of vitamin D levels, bone metabolic marker levels, and bone mineral density among patients with thyroid disease: a Cross-Sectional Study 

21. Management of prediabetes in Malaysian population: An experts’ opinion Management of prediabetes in Malaysian population: An experts’ opinion 

22. Assessing Glycaemic Control in Primary Care Setting: A Randomized Control Trial between Fasting and 2 Hours Postprandial Blood Glucose Monitoring in Type 2 Diabetic Patients Attending Klinik Rawatan Keluarga, Hospital Universiti Sains Malaysia, Kelantan

23. Evaluation of direct medical cost among outpatients of type 2 diabetes mellitus: cost analysis in teaching hospital of Malaysia. 

24. Ensuring the standard of medical graduates in Malaysia  

25. Medical Schools: The supply and availability of qualified human resources-challenges and opportunities  

26. A RANDOMIZED, DOUBLE-BLIND, PLACEBO-CONTROLLED, MULTI-CENTER, CROSS-OVER STUDY OF ROSUVASTATIN IN CHILDREN AND ADOLESCENTS (AGED 6 TO <18 YEARS) WITH HOMOZYGOUS FAMILIAL HYPERCHOLESTEROLEMIA (HOFH) 

27. A Randomized, Placebo-Controlled Crossover Study to Evaluate Postprandial Glucometabolic Effects of Mulberry Leaf Extract, Vitamin D, Chromium, and Fiber in People with Type 2 Diabetes

28. Current insights on dyslipidaemia management for prevention of atherosclerotic cardiovascular disease: A Malaysian perspective 

29. Safety of sodium–glucose c otransporter 2 inhibitors in Asian type 2 diabetes populations  

30. DiabCare Malaysia: Journey to improving diabetes care in Malaysia 

31.  Translation and cross-cultural adaptation of the Malay version of the painDETECT Questionnaire.  

32. Needlestick Injuries With Insulin Injections: Risk Factors, Concerns, and Implications of the Use of Safety Pen Needles in the Asia-Pacific Region 

33.  Practical guide in using insulin degludec/insulin aspart: A multidisciplinary approach in Malaysia  

34. Initiating or Switching to Insulin Degludec/Insulin Aspart in Adults with Type 2 Diabetes in Malaysia: Results from a Prospective, Non-interventional Real-World Study 

35. INITIATING/SWITCHING TO INSULIN DEGLUDEC/INSULIN ASPART (IDEGASP) IN MALAYSIAN PATIENTS WITH TYPE 2 DIABETES IN REAL-WORLD SETTING 

36. IDegAsp treatment in adults with type 2 diabetes in real-world practice: subgroup analysis by dosing frequency  

37. IDegAsp treatment in adults with type 2 diabetes in real-world practice: clinical outcomes by prior therapy subgroup 

38. IDegAsp treatment was associated with improved glycaemic control and reduced hypoglycaemia rates: a real-world study 

39. Using a Diabetes Kidney Disease (DKD) Registry to Treat to Multiple Targets (TMT)—A JADE Technology-Based RCT 

40. Gangguan akibat kekurangan iodin dan pencegahannya di Malaysia 

41. 1st Asean Conference on Medical Sciences18th–21th May 2001Held at the Renaissance Hotel Kota Bharu, Kelantan, Malaysia. 

42. Metabolic syndrome among male patients undergoing coronary angiogram 

43. 173-LB: Using a Diabetes Kidney Disease (DKD) Registry to Treat to Multiple Targets (TMT)—A JADE Technology-Based RCT 

44. Atrasentan and renal events in patients with type 2 diabetes and chronic kidney disease (SONAR): a double-blind, randomised, placebo-controlled trial 

45. LEAN MASS, AGE AND SCLEROSTIN LEVELS INFLUENCE BONE HEALTH IN POSTMENOPAUSAL WOMEN WITH TYPE 2 DIABETES

46. Metabolic Syndrome among Patients Undergoing Coronary Angiogram in a Tertiary Center East Coast of Peninsular Malaysia.

 MJMS and the Challenges of a Research University